| 12213 (705) Renal Pathophysiology and Bartter Syndrome in the Preterm Infant Pat Hummel, MA NNP-BC PNP-BC
 
 Abstract
 
 STATED PURPOSE FOR  THE SESSION: To provide information on renal physiology and antenatal  Bartter Syndrome
 BACKGROUND AND  IMPORTANCE: Bartter Syndrome, is a rare autosomal recessive genetic  disorder diagnosed in a preterm infant via clinical presentation and confirmed  by DNA analysis. Bartter Syndrome is a set of related disorders that present  with hypochloremia, hypokalemia, and metabolic alkalosis. Three main types of  Bartter Syndrome are found; the antenatal form is the most severe, presenting  with prematurity secondary to polyhydramnios, severe electrolyte wasting, and  increased urinary calcium excretion leading to nephrocalcinosis and osteopenia.  The antenatal form is also known as hyperprostaglandin-E syndrome. This renal  tubular disorder involves the distal convoluted tubule, with impaired  reabsorption of chloride, potassium, and calcium. Other features noted with  this infant are sensorineural hearing loss and hydrocephalus. Diagnosis was  complicated due to the infant’s preterm birth and severe bronchopulmonary  dysplasia (BPD), which presents clinically with hypochloremia and hypokalemia  due to diuretic therapies. The pathognomonic feature of this infant’s  presentation was hypopnea. His respiratory rate was consistently 20-26  breaths/minute, atypical for an infant with BPD. His hypoventilation, with  elevated pCO2 levels was compensatory for the metabolic alkalosis induced by  his hypochloremia and hypokalemia.
 
 DESCRIPTION  OF WHAT WILL BE COVERED: A case study of the infant’s course is presented.  Diagnosis, pathophysiology, treatment, and prognosis of Bartter Syndrome are  outlined.
 
 FUTURE DIRECTIONS:  Continued research of Bartter Syndrome diagnosis and treatment options.
 
 Learning Objectives
 1.  Describe renal physiology.
 2.  Explain renal tubular defects and describe Bartter syndrome pathophysiology.
 3.  Discuss Bartter syndrome diagnosis, treatment, and prognosis.
 
 Bibliography
 1. Chadha, V., & Alon, U. S. (2009).  Hereditary renal tubular disorders. Seminars in Nephrology, 29(4), 399-411.
 2. Komhoff, M., Tekesin, I., Peters, M., Leonhard, A., & Seyberth, H. W.  (2005). Perinatal management of a preterm neonate affected by  hyperprostaglandin E2 syndrome (HPS). Acta Paediatrica, 94(11), 1690-1693.
 3. Onem, Y., Kucukardali, Y., Sahan, B., Atasoyu, E. M., Ipcioglu, O.,  Terekeci, H., et al. (2008). Analyses of subjects with hypokalemic metabolic  alkolosis, Gitelman's and Bartter's syndrome. Renal Failure, 30(7), 691-694.
 4. Vaisbich, M. H., Fujimura, M. D., & Koch, V. H. (2004). Bartter  syndrome: benefits and side effects of long-term treatment. Pediatric  Nephrology, 19(8), 858-863.
 5. Vieux, R., Hamon, I., Feldmann, M., Andre, J. L., & Hascoet, J. M.  (2009). Neonatal Bartter syndrome's special features in very premature  newborns. Archives of Pediatrics, 16(1), 23-26.
 
 |